<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR105">
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Jiang</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Cao</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Bright</surname>
    <given-names>DK</given-names>
   </name>
   <name>
    <surname>Bever</surname>
    <given-names>AM</given-names>
   </name>
   <name>
    <surname>Blakney</surname>
    <given-names>AK</given-names>
   </name>
   <name>
    <surname>Suydam</surname>
    <given-names>IT</given-names>
   </name>
   <name>
    <surname>Woodrow</surname>
    <given-names>KA</given-names>
   </name>
  </person-group>
  <article-title>Nanoparticle-based ARV drug combinations for synergistic inhibition of cell-free and cell-cell HIV transmission</article-title>
  <source>Mol Pharm</source>
  <year>2015</year>
  <volume>12</volume>
  <fpage>4363</fpage>
  <lpage>4374</lpage>
  <pub-id pub-id-type="doi">10.1021/acs.molpharmaceut.5b00544</pub-id>
  <?supplied-pmid 26529558?>
  <pub-id pub-id-type="pmid">26529558</pub-id>
 </element-citation>
</ref>
